LAST
发表于 2025-3-30 09:47:21
Robert D. Martin,Warren Boling,John H. ZhangSummarizes the latest studies on acute and delayed neurovascular injuries after subarachnoid hemorrhage.Covers new pilot treatments, clinical trials, academic and industrial interactions.Discusses ani
Heresy
发表于 2025-3-30 13:22:41
Springer Nature Switzerland AG 2020
Ruptured-Disk
发表于 2025-3-30 17:23:46
http://reply.papertrans.cn/89/8813/881239/881239_53.png
蚀刻术
发表于 2025-3-30 21:58:43
oxy RA, 4-oxo RA, and 1%hydroxy RA. 13-. RA also binds to RARs, but with a .. value higher than the former group. Retinol can also induce responses in RA-sensitive systems; generally at doses ~200-fold higher than RA. In RA-dependent responses, retinol probably functions through conversion into RA (
organic-matrix
发表于 2025-3-31 02:02:06
http://reply.papertrans.cn/89/8813/881239/881239_55.png
Chagrin
发表于 2025-3-31 06:13:26
Kenji Kanamaruoxy RA, 4-oxo RA, and 1%hydroxy RA. 13-. RA also binds to RARs, but with a .. value higher than the former group. Retinol can also induce responses in RA-sensitive systems; generally at doses ~200-fold higher than RA. In RA-dependent responses, retinol probably functions through conversion into RA (
Medley
发表于 2025-3-31 11:07:43
http://reply.papertrans.cn/89/8813/881239/881239_57.png
BALK
发表于 2025-3-31 16:54:38
Warren Boling,Lydia Kore(as with the corticosteroids). This is certainly the case with the retinoids. Here are drugs that are active in psoriasis (plaque type, erythro-dermic, pustular and arthropathic), the disorders of keratinization (including the ichthyotic disorders, erythrokeratoderma variabilis and Darier’s disease)
arthroscopy
发表于 2025-3-31 21:32:36
(as with the corticosteroids). This is certainly the case with the retinoids. Here are drugs that are active in psoriasis (plaque type, erythro-dermic, pustular and arthropathic), the disorders of keratinization (including the ichthyotic disorders, erythrokeratoderma variabilis and Darier’s disease)
GRATE
发表于 2025-3-31 21:56:39
Alejandra N. Martinez,Crissey L. Pascale,Peter S. Amenta,Rachel Israilevich,Aaron S. Dumont der Rhee ... regularly measured the height and urinary hydroxyproline excretion in five children during treatment with etretinate. No signs of growth retardation were found for the treatment periods studied (varying between 11 and 17 months). Tamayo and Ruiz-Maldonado. concluded from their experien